Form 8-K - Current report:
SEC Accession No. 0001104659-21-123485
Filing Date
2021-10-06
Accepted
2021-10-06 07:15:27
Documents
12
Period of Report
2021-10-01
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2129116d1_8k.htm   iXBRL 8-K 34540
  Complete submission text file 0001104659-21-123485.txt   210578

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vygr-20211001.xsd EX-101.SCH 3222
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vygr-20211001_lab.xml EX-101.LAB 34594
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vygr-20211001_pre.xml EX-101.PRE 22735
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2129116d1_8k_htm.xml XML 3489
Mailing Address 75 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 75 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37625 | Film No.: 211308815
SIC: 2836 Biological Products, (No Diagnostic Substances)